Nectar Lifesciences receives 7 observations from EDQM for API facility
The European regulator will conduct a re-inspection of the facility to verify the compliance
The European regulator will conduct a re-inspection of the facility to verify the compliance
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Overall investment in the US facility is estimated around US$50 million
This e-commerce platform is launched as a hyperlocal model
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
ANVIMO will be available in dosages of 240 mg and 480 mg
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Subscribe To Our Newsletter & Stay Updated